Drug-mediated marrow purging: mafosfamide in adult acute leukemia in remission. The experience of the Italian study group

Bone Marrow Transplant. 1989 Jan:4 Suppl 1:190-4.

Authors

U Rizzoli¹, L Mangoni, A M Carella, M Aglietta, A Porcellini, P Coleselli, F Angrilli, E P Alessandrino, E Madon, F Locatelli, et al.

Affiliation

¹ Cattedra di Enotologia, Parma, Italy.

PMID: 2653502

No abstract available

Publication types

Clinical Trial
Comparative Study
Controlled Clinical Trial
Multicenter Study
Research Support, Non-U.S. Gov't

MeSH terms

Adolescent
Adult
Bone Marrow / pathology
Bone Marrow Transplantation*
Busulfan / therapeutic use
Child
Cyclophosphamide / analogs & derivatives*
Cyclophosphamide / therapeutic use
Drug Evaluation
Humans
Infant
Italy
Leukemia, Myeloid, Acute / pathology
Leukemia, Myeloid, Acute / surgery*
Middle Aged
Multicenter Studies as Topic
Neoplastic Stem Cells / drug effects
Neoplastic Stem Cells / radiation effects
Postoperative Care
Precursor Cell Lymphoblastic Leukemia-Lymphoma / pathology
Precursor Cell Lymphoblastic Leukemia-Lymphoma / surgery*
Preoperative Care*
Whole-Body Irradiation

Substances

mafosfamide
Cyclophosphamide
Busulfan